UK Authorizes ‘Gamechanger’ AstraZeneca Vaccine Despite Data Doubts

MHRA Rejects Low Dose Data

 
• By Andrew McConaghie

UK regulator admits evidence sparse on older patients, but believes longer gap between doses can boost efficacy and accelerate numbers of people immunized.

UK COVID Tier 4
Much of England is now in 'Tier 4' where the infection rate is being driven up by the new COVID-19 variant.

More from COVID-19

More from Scrip